US Patent 11944664 Fibroblast growth factor-21-Fc fusion proteins
Patent 11944664 was granted and assigned to Novartis on April, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11944664 Fibroblast growth factor-21-Fc fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
